4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-24-000204
Chief Legal Officer acquired 109,956 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Van Tuyl Christopher Chief Legal Officer | 2024-12-16 | Grant or award | +109,956 | 109,956 | D | ||
| Derivatives | |||||||
| Van Tuyl Christopher Chief Legal Officer | 2024-12-16 | Grant or award · Stock Option (right to buy) | +137,446 | 137,446 | D | ||
Loading xslF345X05/wk-form4_1734559363.xml…